Tilray Brands, Inc. ( TLRY) - Key Metrics
TLRY Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2027Q1 | $1.93 | -$0.32 | -$0.12 | -$0.21 |
| 2026Q4 | $2.52 | -$0.44 | -$0.34 | -$0.43 |
| 2026Q3 | $1.83 | -$0.24 | -$0.20 | -$0.23 |
| 2026Q2 | $1.97 | -$0.41 | -$0.11 | -$0.23 |
| 2026Q1 | $1.98 | $0 | -$0.02 | -$0.14 |
TLRY Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2027Q1 | 0% | -3.57 |
| 2026Q4 | 0% | -3.19 |
| 2026Q3 | 0% | -8.20 |
| 2026Q2 | 0% | -4.77 |
| 2026Q1 | 0% | -862.50 |
TLRY
Price: $2.53
52 week price:
Earnings Per Share: -1.41 USD
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: Canada
Volume: 12.7 million
Market Capitalization: 483.3 million